Abstract
Nanomedicine is one of the most dynamic, lucrative and productive contemporary research streams; it is playing an intimate role in the progression of modern medicine through the development of new and highly innovative treatments as well as improving and enhancing established techniques. But what is nanomedicine and why the pomp and ceremony? This chapter aims to dissect nanomedicine with the intention of both defining it as a field and demonstrating its worthiness to receive the title of ‘revolutionary interdiscipline’. With this in mind, the field is introduced as combination of three distinct subsections: nanobiotechnology, nanotechnology and nanobiomimetics, and also through the two main synthetic approaches, top-down and bottom-up, both of which are pivotal in separating the enhancement of existing technology from the development of revolutionary new technology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Feynman RP (1960) There’s plenty of room at the bottom. Eng Sci 23:22–36
Sabatier PA (1986) Top-down and bottom-up approaches to implementation research: a critical analysis and suggested synthesis. J Public Policy 6:21–48
Brzicová T, Feliu N, Fadeel B (2014) Research highlights: highlights from the last year in nanomedicine. Nanomedicine 9(1):17–20
Bogue R (2013) Inspired by nature at the nanoscale. Sens Rev 33:19–24
Bhushan B (2010) Springer handbook of nanotechnology. Springer, Berlin
Whitesides GM (2003) The ‘right’ size in nanobiotechnology. Nat Biotechnol 21:1161–1165
Noyce RN (1977) Microelectronics. Sci Am 237:63–69
Brock DC (2006) Understanding Moore‘s law: four decades of Innovation. CHF Publications, Philadelphia
Shi Z, Kochergin V, Wang F (2009) 193 nm superlens imaging structure for 20 nm lithography node. Opt Express 17:11309–11314
Veedu VP, Cao AY, Li XS, Ma KG, Soldano C, Kar S, Ajayan PM, Ghasemi-Nejhad MN (2006) Multifunctional composites using reinforced laminae with carbon-nanotube forests. Nat Mater 5:457–462
Quaresimin M, Varley RJ (2008) Understanding the effect of nano-modifier addition upon the properties of fibre reinforced laminates. Compos Sci Technol 68:718–726
Lee SW, Chang W-J, Bashir R, Koo Y-M (2007) “Bottom-up” approach for implementing nano/microstructure using biological and chemical interactions. Biotechnol Bioprocess Eng 12:185–199
Wang YL, Xia YN (2004) Bottom-up and top-down approaches to the synthesis of monodispersed spherical colloids of low melting-point metals. Nano Lett 4:2047–2050
Haupt K, Mosbach K (2000) Molecularly imprinted polymers and their use in biomimetic sensors. Chem Rev 100:2495–2504
Zhang H, Fung KH, Hartmann J, Chan CT, Wang DY (2008) Controlled chainlike agglomeration of charged gold nanoparticles via a deliberate interaction balance. J Phys Chem C 112:16830–16839
Krein SL, Vijan S, Pogach LM, Hogan MM, Kerr EA (2002) Aspirin use and counseling about aspirin among patients with diabetes. Diabetes Care 25:965–970
Chan AT, Fuchs CS, Ogino S (2009) Aspirin use and survival after diagnosis of colorectal cancer. Gastroenterology 136:A55
Elmissiry M, Mahdy A, Ghoniem G (2011) Treatment of female stress urinary incontinence: what women find acceptable and the impact of clinical and urodynamic evaluation on their final choice. Scandanavian J Urol Nephrol 45:326–331
Frampton JE, Plosker GL (2007) Duloxetine: a review of its use in the treatment of major depressive disorder. CNS Drugs 21:581–609
Cheitlin MD, Hutter AM Jr, Brindis RG, Ganz P, Kaul S, Russell RO Jr, Zusman RM (1999) Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee. Circulation 99:168–177
Lalej-Bennis D, Sellam R, Selam JL, Slama G (2000) How to prescribing Viagra in practice…. Diabetes Metab 26:416–420
Dordick JS, Lee KH (2014) Editorial overview: nanobiotechnology. Curr Opin Biotechnol 28:iv–v
Schwaber J, Cohen EP (1973) Human x mouse somatic cell hybrid clone secreting immunoglobulins of both parental types. Nature 244:444–447
Bastian LA, Nanda K, Hasselblad V, Simel DL (1998) Diagnostic efficiency of home pregnancy test kits. A meta-analysis. Arch Fam Med 7:465–469
Kannangai R, Ramalingam S, Prakash KJ, Abraham OC, George R, Castillo RC, Schwartz DH, Jesudason MV, Sridharan G (2001) A peptide enzyme linked immunosorbent assay (ELISA) for the detection of human immunodeficiency virus type-2 (HIV-2) antibodies: an evaluation on polymerase chain reaction (PCR) confirmed samples. J Clin Virol 22:41–46
Cordes RJ, Ryan ME (1995) Pitfalls in HIV testing. Application and limitations of current tests. Postgrad Med 98:177–180
Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285:1569–1572
Jo D, Liu DY, Yao S, Collins RD, Hawiger J (2005) Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. Nat Med 11:892–898
Yamanaka R (2004) Alphavirus vectors for cancer gene therapy (Review). Int J Oncol 24:919–923
Cortez-Retamozo V, Backmann N, Senter PD, Wernery U, De Baetselier P, Muyldermans S, Revets H (2004) Efficient cancer therapy with a nanobody-based conjugate. Cancer Res 64:2853–2857
Goel A, Colcher D, Baranowska-Kortylewicz J, Augustine S, Booth BJM, Pavlinkova G, Batra SK (2000) Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49: improved biodistribution and potential for therapeutic application. Cancer Res 60:6964–6971
Kreuter J, Shamenkov D, Petrov V, Ramge P, Cychutek K, Koch-Brandt C, Alyautdin R (2002) Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target 10:317–325
Modi G, Pillay V, Choonara YE, Ndesendo VMK, Du Toit LC, Naidoo D (2009) Nanotechnological applications for the treatment of neurodegenerative disorders. Prog Neurobiol 88:272–285
Liu G, Swierczewska M, Lee S, Chen X (2010) Functional nanoparticles for molecular imaging guided gene delivery. Nano Today 5:524–539
Chen Y, Xue Z, Zheng D, Xia K, Zhao Y, Liu T, Long Z, Xia J (2003) Sodium chloride modified silica nanoparticles as a non-viral vector with a high efficiency of DNA transfer into cells. Curr Gene Ther 3:273–279
Krpetić Z, Anguissola S, Garry D, Kelly PM, Dawson KA (2014) Nanomaterials: impact on cells and cell organelles. In: Nanomaterial. Springer, Netherlands, pp 135–156
Dobson J (2006) Magnetic nanoparticles for drug delivery. Drug Dev Res 67:55–60
Mcbain SC, Yiu HHP, Dobson J (2008) Magnetic nanoparticles for gene and drug delivery. Int J Nanomedicine 3:169–180
Kim DH, Kim KN, Kim KM, Lee YK (2009) Targeting to carcinoma cells with chitosan- and starch-coated magnetic nanoparticles for magnetic hyperthermia. J Biomed Mater Res A 88A:1–11
Tani J, Faustineand Sufian JT (2011) Updates on current advances in gene therapy. West Indian Med J 60:188–194
Kito A, Yoshida J, Kageyama N (1987) Basic studies on chemotherapy of brain tumors by means of liposomes: affinity of sulfatide-inserted liposomes to human glioma cells. Brain Nerve 39:783–788
Kikuchi H (2004) Application of stealth liposomes to cancer chemotherapy and gene therapy. Biotherapy 18:353–360
Fortier C, Durocher Y, De Crescenzo G (2014) Surface modification of nonviral nanocarriers for enhanced gene delivery. Nanomedicine 9(1):135–151
Pradhan P, Giri J, Rieken F, Koch C, Mykhaylyk O, Doblinger M, Banerjee R, Bahadur D, Plank C (2010) Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. J Control Release 142:108–121
Giljohann DA, Seferos DS, Daniel WL, Massich MD, Patel PC, Mirkin CA (2010) Gold nanoparticles for biology and medicine. Angew Chem-Int Ed 49:3280–3294
Salata O (2004) Applications of nanoparticles in biology and medicine. J Nanobiotechnol 2:3
Liu Z, Tabakman S, Welsher K, Dai H (2009) Carbon nanotubes in biology and medicine: in vitro and in vivo detection, imaging and drug delivery. Nano Res 2:85–120
Xiong MP, Bae Y, Fukushima S, Forrest ML, Nishiyama N, Kataoka K, Kwon GS (2007) pH-responsive multi-PEGylated dual cationic nanoparticles enable charge modulations for safe gene delivery. ChemMedChem 2:1321–1327
Wu GY, Wu CH (1987) Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem 262:4429–4432
Hirst AR, Escuder B, Miravet JF, Smith DK (2008) High-tech applications of self-assembling supramolecular nanostructured gel-phase materials: from regenerative medicine to electronic devices. Angew Chem-Int Ed 47:8002–8018
Chhabra R, Sharma J, Liu Y, Rinker S, Yan H (2010) DNA self-assembly for nanomedicine. Adv Drug Deliv Rev 62:617–625
Yan H, Yin P, Park SH, Li HY, Feng LP, Guan XJ, Liu DG, Reif JH, Labean TH (2004) Self-assembled DNA structures for nanoconstruction, DNA-based molecular electronics: international symposium on DNA-based molecular electronics, 725:43–52
Hosseinkhani H, Hosseinkhani M, Kobayashi H (2006) Design of tissue-engineered nanoscaffold through self-assembly of peptide amphiphile. J Bioact Compat Polym 21:277–296
Kumar CSSR (2010) Biomometic and bioinspired nanomaterials. Wiley, Weinheim
Li S, Ge Y, Piletsky SA, Lunec J (2012) Molecularly imprinted sensors: overview and applications. Elsevier, Boston
Haupt K (2003) Peer reviewed: molecularly imprinted polymers: the next generation. Anal Chem 75:376 A–383 A
Bossi A, Bonini F, Turner APF, Piletsky SA (2007) Molecularly imprinted polymers for the recognition of proteins: the state of the art. Biosens Bioelectron 22:1131–1137
Bui BTS, Haupt K (2010) Molecularly imprinted polymers: synthetic receptors in bioanalysis. Anal Bioanal Chem 398:2481–2492
Ruigrok VJ, Levisson M, Eppink MH, Smidt H, Van Der Oost J (2011) Alternative affinity tools: more attractive than antibodies? Biochem J 436:1–13
Lulinski P (2011) Molecularly imprinted polymers in pharmaceutical sciences. Part II. Applications in pharmaceutical analysis. Polimery 56:3–10
Lulinski P (2010) Molecularly imprinted polymers in pharmaceutical sciences. Part I. The principles of molecular imprinting. Applications in drug synthesis and drug delivery systems. Polimery 55:799–805
O’sullivan CK (2002) Aptasensors–the future of biosensing? Anal Bioanal Chem 372:44–48
Lim YC, Kouzani AZ, Duan W (2010) Aptasensors: a review. J Biomed Nanotechnol 6:93–105
Giovannoli C, Baggiani C, Anfossi L, Giraudi G (2008) Aptamers and molecularly imprinted polymers as artificial biomimetic receptors in affinity capillary electrophoresis and electrochromatography. Electrophoresis 29:3349–3365
Abelow AE, Schepelina O, White RJ, Vallee-Belisle A, Plaxco KW, Zharov I (2010) Biomimetic glass nanopores employing aptamer gates responsive to a small molecule. Chem Commun (Camb) 46:7984–7986
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bates, F. (2014). Nanomedicine: Revolutionary Interdiscipline. In: Ge, Y., Li, S., Wang, S., Moore, R. (eds) Nanomedicine. Nanostructure Science and Technology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-2140-5_1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-2140-5_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-2139-9
Online ISBN: 978-1-4614-2140-5
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)